在退行性肌肉骨疾病中的虹膜素:系统中的功能和治疗中的潜力
Yu-Tong Wang1, Sheng-Yuan Zheng2, Shi-de Jiang3
1Department of Orthopedics, Xiangya Hospital, Central South University, Changsha, Hunan, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China; Department of Clinical Medicine, Xiangya Medicine School, Central South University, Changsha, Hunan, China.
Pharmacological research
|November 4, 2024
概括
虹膜素是预防和治疗退行性肌肉骨疾病 (如骨关节炎和骨质疏松症) 的关键分子. 这篇评论探讨了伊丽素.
科学领域:
- 生物医学科学 生物医学科学
- 肌肉骨健康 肌肉骨健康
- 衰老研究研究 衰老研究
背景情况:
- 退行性肌肉骨疾病,包括骨关节炎 (OA),骨质疏松症 (OP),肉症 (SP) 和椎间盘退行 (IDD),显著影响人口老龄化和医疗保健系统.
- 确定关键的调节因素和治疗目标对于管理这些渐进性疾病至关重要.
- 新兴研究突出显示,虹膜素在退行性肌肉骨疾病的病理生理学中起着重要的作用.
研究的目的:
- 为了提供一个全面的概述伊丽素的释放和基本功能.
- 总结伊丽素在细胞和组织层面的OA,OP,SP和IDD中的多方面的作用.
- 探索伊丽素作为退行性肌肉骨疾病的治疗点的潜力.
主要方法:
- 文献综述综合了最近关于虹膜素和退行性肌肉骨疾病的科学研究.
- 对伊丽素参与与OA,OP,SP和IDD相关的细胞和组织水平变化的分析.
- 检查虹膜素在骨肌脂肪交叉,炎症,衰老和细胞死亡中的功能.
主要成果:
- 虹膜素显示出在OA,OP,SP和IDD的进展和潜在治疗方面具有显著的参与.
- 虹膜素在骨,肌肉和脂肪组织之间的复杂相互作用中充当关键信号分子.
- 虹膜在炎症,细胞衰老和亡中的调节功能与肌肉骨健康有关.
结论:
- 虹膜素成为预防和治疗退行性肌肉骨疾病的有希望的关键分子.
- 了解虹膜素的作用为开发新型临床应用提供了基础.
- 对伊丽素机制的进一步研究可能会为与年龄相关的肌肉骨衰退开启新的治疗策略.
相关概念视频
iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
Inflammatory Bowel Disease IV: Pharmacological Management
116
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
116
siRNA - Small Interfering RNAs
16.6K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.6K


